Effects of eating dates on hunger and appetite in adults with Type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates how consuming three Baghdad dates daily affects hedonic hunger and appetite hormones in adults diagnosed with Type 2 diabetes. Participants will be randomly assigned to either an intervention group, which will include date consumption as part of their breakfast, or a control group that will not consume dates. The study aims to measure changes in appetite-related hormones and various health markers over a 12-week period. The research will also assess the impact of date consumption on lipid profiles and glycemic control in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals diagnosed with Type 2 diabetes aged 19-50 years (excluding menopausal women),
* Individuals with BMI between 25-35 kg/m2,
* Individuals with a Nutritional Strength Scale score of 2.5 and above,
* Individuals who agreed not to start taking new dietary supplements or alternative therapies during the study period,
* Individuals who agree not to change their current physical activity level and diet.

Exclusion Criteria:

* Individuals who do not approve the volunteer consent form,
* Individuals with a Nutritional Strength Scale score below 2.5,
* Pregnant or breastfeeding women (or women planning to become pregnant within 3 months)
* Individuals with dietary energy \<800 kcal/day and \>4000 kcal/day,
* Individuals with pre-diabetes, type 1 diabetes and gestational diabetes,
* Individuals with HbA1c \>10
* Individuals taking antibiotics or hormone replacement therapy History of malignancy (except non-melanoma skin cancer).
* Individuals with regular consumption of dates before inclusion in the study,
* Individuals diagnosed with Type 2 diabetes using insulin and oral antidiabetic drugs with thiazolidinedione active substance,
* Individuals with a history of diabetic ketoacidosis, diabetic coma or precoma within 6 months prior to the date of admission; serious infections, surgery, serious trauma requiring insulin treatment, haemodialysis treatment (including peritoneal haemodialysis), serious liver injury and serious vascular complications (stroke, myocardial infarction and heart failure) requiring hospitalisation,
* Individuals taking pharmacological agents that have effects on appetite such as psychotropics, antiepileptics, antidepressants, antipsychotics and/or steroids,
* Individuals diagnosed with eating disorders and/or psychological disorders,
* Individuals with physical illnesses that affect eating behaviour or appetite, such as uncontrolled hyperthyroidism or hypothyroidism, Cushing's disease, acromegaly, adrenal insufficiency, chronic renal failure (stage 4 or 5), tuberculosis, human immunodeficiency virus (HIV) infection.

Where it's running

• Erzurum City Hospital
  Erzurum, Palandöken, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Ayşe Çamli̇
• Email: aysecamli1996@gmail.com
• Phone: +905364254169

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Chromium Picolinate for Appetite and Cravings in Overweight Adults

  A remote 8-week program tests whether daily chromium picolinate helps reduce hunger and cravings in adults with BMI 25–31 who are overweight.

  Recruiting Nutrition 21, Inc. · Los Angeles, California · NCT07909109

• Acupuncture plus vitamin B12 for diabetic heart nerve damage

  This study tests whether adding acupuncture to standard care and vitamin B12 can help adults with type 2 diabetes who have damaged the nerves that control the heart.

  Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07907536

• Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes

  This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07868666

• White potato meals and when you eat them: how timing changes blood sugar and appetite

  This study tests how eating white potatoes with meals at different times affects blood sugar, hunger, and how much people eat later in healthy adults.

  Recruiting Toronto Metropolitan University · Toronto, Ontario · NCT07854938

• Body composition changes after starting GLP-1 therapies in adults with obesity or type 2 diabetes

  This study will follow adults with obesity and/or type 2 diabetes who are starting or adjusting a GLP-1 receptor agonist to see how their muscle and fat change over about a year.

  Recruiting at 2 sites Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Mexico City, Mexico City and 1 other locations · NCT07835360

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.